Viking Therapeutics VKTX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Viking Therapeutics’s reported figures.
The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viking Therapeutics's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viking Therapeutics's enterprise value?
- Viking Therapeutics (VKTX) reported enterprise value of $3.81B in Q4 2025.
- How has Viking Therapeutics's enterprise value changed year-over-year?
- Viking Therapeutics's enterprise value decreased by 14.5% year-over-year, from $4.46B to $3.81B.
- What is the long-term trend for Viking Therapeutics's enterprise value?
- Over 5 years (2020 to 2025), Viking Therapeutics's enterprise value has grown at a 56.1% compound annual growth rate (CAGR), from $411.7M to $3.81B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.